Selected market
Philippines
The Philippines separates FDA authorisation, HTA advice, funding decisions, procurement and provider delivery; the applicable arrangement depends on the product and care setting.
FDA CDRR / FDA-licensed applicant
DOH / PhilHealth / private payer / provider
DOH or PhilHealth / DOST HTA Division / HTAC
Assessment team / HTAC / stakeholders
HTAC / DOH or PhilHealth decision-maker
9 decision nodes29 cited sources